Ingevity Corporation
NGVT
$72.24
$0.260.36%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.07% | -3.11% | -0.21% | 26.09% | -27.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.07% | -3.11% | -0.21% | 26.09% | -27.11% |
| Cost of Revenue | 4.12% | 6.49% | -1.48% | 57.46% | -43.43% |
| Gross Profit | 4.02% | -17.33% | 1.75% | -4.27% | 12.24% |
| SG&A Expenses | -2.86% | 8.90% | 16.36% | 26.74% | -11.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.22% | 7.19% | 1.62% | 51.13% | -37.30% |
| Operating Income | 9.52% | -36.91% | -5.37% | -18.37% | 39.38% |
| Income Before Tax | -19.68% | -536.93% | 15.19% | 6.95% | 152.29% |
| Income Tax Expenses | -20.00% | -688.89% | 229.23% | 134.51% | 153.46% |
| Earnings from Continuing Operations | -19.59% | -502.04% | -14.11% | -6.72% | 151.96% |
| Earnings from Discontinued Operations | 523.26% | -93.33% | 101.75% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 191.71% | -609.64% | 140.58% | 48.36% | 136.61% |
| EBIT | 9.52% | -36.91% | -5.37% | -18.37% | 39.38% |
| EBITDA | 2.84% | -23.18% | -4.66% | -19.59% | 17.51% |
| EPS Basic | 200.99% | -615.49% | 140.62% | 48.51% | 136.49% |
| Normalized Basic EPS | 30.50% | -96.40% | -1.28% | -41.34% | 1,369.75% |
| EPS Diluted | 198.99% | -616.10% | 139.91% | 48.61% | 135.97% |
| Normalized Diluted EPS | 28.74% | -96.40% | -2.61% | -41.02% | 1,359.96% |
| Average Basic Shares Outstanding | -3.09% | -1.72% | -0.10% | 0.33% | 0.33% |
| Average Diluted Shares Outstanding | -1.76% | -1.72% | 1.27% | 0.33% | 1.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |